Cytokinetics Calls for Donations
Cytokinetics, Incorporated (NASDAQ: CYTK) shares cleared breakeven Tuesday, as the company called for proposals for its annual Cytokinetics Corporate Giving Program.
The program provides charitable donations to eligible non-profit organizations in the United States to support equitable healthcare initiatives for cardiovascular disease, diversity in science education and certain essential services for local and at-risk communities.
“As we enter our second year of formalized corporate giving, we are inspired by the strong foundation we built in 2024 and look forward to expanding our impact this year,” said Diane Weiser, Cytokinetics’ Senior Vice President, Corporate Affairs.
“This program is rooted in the power of partnering with non-profit organizations to advance a shared mission and together make a lasting difference across our corporate giving priorities with an emphasis on health equity in cardiovascular disease.”
The Cytokinetics Corporate Giving Program consists of individual charitable donations up to $20,000 for qualified 501(c)(3) organizations in the United States that are neither engaged, nor directly involved in the practice of healthcare.
Specifically, the program will provide funding to organizations with initiatives focused on diversity in science education and certain essential services for local and at-risk communities in the San Francisco Bay Area and Greater Philadelphia Region.
Additionally, it will support eligible organizations dedicated to health equity initiatives in cardiovascular disease across the United States.
CYTK shares marched ahead 18 cents to $33.31.
